Concepedia

Matthew Fidler

MF

Statistics

Publications

6

Citations

233

H-Index

6

Active since

2005

Affiliations

Novartis (United States)(Current)

University of Utah

PNO Consultants (Netherlands)

Integra LifeSciences (United States)

Certara (United States)

Matthew Fidler is an author at Novartis (United States) specializing in pharmacology, pharmacokinetics, and pharmacy.

ORCID

Publications per year

2005–2020

6

Publications

6

Nonlinear Mixed‐Effects Model Development and Simulation Using nlmixr and Related R Open‐Source Packages

Matthew Fidler, Justin Wilkins, Richard Hooijmaijers et al. · CPT Pharmacometrics & Systems Pharmacology · 2019 · 79 citations · Full text

, , +11

Ranibizumab Population Pharmacokinetics and Free VEGF Pharmacodynamics in Preterm Infants With Retinopathy of Prematurity in the RAINBOW Trial

Matthew Fidler, Brian W. Fleck, Andreas Stahl et al. · Translational Vision Science & Technology · 2020 · 43 citations · Full text

, , +17

Pharmacodynamic Attainment of the Synergism of Meropenem and Fosfomycin Combination against Pseudomonas aeruginosa Producing Metallo-β-Lactamase

James Albiero, Josmar Mazucheli, Juliana Pimenta dos Reis Barros et al. · Antimicrobial Agents and Chemotherapy · 2019 · 40 citations

, , +17

Flexible Interaction Model for Complex Interactions of Multiple Anesthetics

Matthew Fidler, Steven E. Kern · Anesthesiology · 2006 · 26 citations · Full text

, , +15

Performance of the SAEM and FOCEI Algorithms in the Open‐Source, Nonlinear Mixed Effect Modeling Tool nlmixr

Rik C. Schoemaker, Matthew Fidler, Christian Laveille et al. · CPT Pharmacometrics & Systems Pharmacology · 2019 · 23 citations · Full text

, , +17

1–5 of 6